The ongoing trial of suspected Gilgo Beach serial killer Rex Heuermann sees his defense attorney contesting the inadmissibility of nuclear DNA evidence. During the court hearing, lawyer Michael Brown argued against the scientific validity of the DNA findings, which were processed by Astrea Labs, marking their first use in New York. Heuermann's defense maintains that they require full disclosure of evidence to prepare for potential Frye hearings, essential for determining the reliability of the DNA evidence presented by prosecutors. The case involves the murder of seven women, with forensic evidence crucial in linking Heuermann to the victims.
Brown's argument highlighted that the nuclear DNA evidence presented was novel and that its scientific reliability is still in question, especially in the context of a criminal trial.
Heuermann's defense team is challenging the admissibility of DNA evidence, emphasizing that the lab which processed the DNA is being used for the first time in cases in New York.
The defense attorney underscored the importance of having all evidence available prior to any hearings, raising concerns that incomplete disclosures could impact fair trial rights.
Collection
[
|
...
]